GRACE :: Lung Cancer

EGFR

Questions & Answers with Drs. Blumenthal and Pennell; Moderated by Dr. West

Share

Acquired Resistance Forum Video #7: Speakers from videos #5 and #6 at the Acquired Resistance in Lung Cancer Patient Forum sat for a moderated Q&A with Dr. Jack West.


Using Non/Off-Targeted Therapies in Targeted Lung Cancer Populations

Share

Acquired Resistance Forum Video #6: Dr. Nate Pennell of the Cleveland Clinic discussed the other options available to patients with ALK, ROS1 and EGFR lung cancer, such as chemotherapy, Avastin, and immunotherapy.


Clinical Trial Design & Development of Highly Targeted Agents in the Molecular Era

Share

Acquired Resistance Forum Video #5: Dr. Gideon Blumenthal of the US Food and Drug Administration (FDA) discussed the FDA process for approving targeted therapies.


Questions & Answers with Drs. Riely, Weiss and Sequist; Moderated by Dr. West

Share

Acquired Resistance Forum Video #4: The first three speakers at the Acquired Resistance in Lung Cancer Patient Forum sat for a moderated Q&A with Dr. Jack West. 


Repeat Biopsies & the Potential Value of Biologically-Informed Acquired Resistance Therapy

Share

Acquired Resistance Forum Video #3: Dr. Lecia Sequist of Massachusetts General Hospital detailed why doctors started doing repeat biopsies for patients receiving targeted therapies and how they help patients and doctors determine next steps in treatment.


Ask Us, Q&A
Lung/Thoracic Cancer Expert Content

Archives

Share

Immunotherapy Patient Forum 2014 Videos

 


GRACE Website Rebuild

Share

Acquired Resistance Forum Videos

 

ALK+ Lung Cancer Patient Forum Videos

Share

Join the GRACE Faculty

Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog
Share

Subscribe to the GRACEcast Podcast on iTunes

Share

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

Share

ClinicalTrials.gov


Biomedical Learning Institute

peerview_institute_logo_243